Identification of a risk factor for clozapine-induced sialorrhea
Not Applicable
- Conditions
- schizophrenia
- Registration Number
- JPRN-UMIN000026822
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patient changing dosage of clozapine
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method this study evaluates the association between the blood concentration of clozapine and metabolite and Drooling Severity and Drooling Frequency Scale.
- Secondary Outcome Measures
Name Time Method this study evaluates the association between the dysphagia, extrapyramidal symptom and Drooling Severity and Drooling Frequency Scale.